FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDRH Consensus Standard Guidances

[ Price : $8.95]

CDRH issues three guidances on using consensus standards to satisfy premarket review requirements.

FDA OKs Seroquel Expanded Use

[ Price : $8.95]

FDA approves an AstraZeneca supplemental NDA for Seroquel XR (quetiapine fumarate) and its expanded use as maintenance treatment i...

Gilead Science NDA for Cystic Fibrosis Patients

[ Price : $8.95]

Gilead Sciences submits an NDA for aztreonam lysine for inhalation (75 mg three times daily), an investigational therapy for treat...

GSK Intimidated Avandia Researcher: Grassley

[ Price : $8.95]

Sen. Chuck Grassley says GlaxoSmithKline tried to intimidate a university researcher who raised early questions about Avandia safe...

Gottlieb: FDA Unprepared for Follow-on Biologics

[ Price : $8.95]

Former FDA deputy commissioner for medical and scientific affairs Scott Gottlieb says organizational changes are needed at FDA to ...

FDA Seizes Dangerous Eyelash Cosmetic

[ Price : $8.95]

FDA orders the seizure of Jan Marini Skin Researchs Age Intervention Eyelash in San Jose as an unapproved and misbranded drug that...

Scharmann Responds to Foreign Inspections Comments

[ Price : $8.95]

Consulting editor John Scharmann responds to FDA field employees comments on his recent article, FDAs Foreign Model Could be Good ...

FDA Clears Medtronic Biliary Stent

[ Price : $8.95]

FDA clears a Medtronic 510(k) for the Complete SE (self-expanding) Biliary Stent System, indicated for use in the palliative treat...

FDA Addresses Unretrieved Device Fragment Injuries

[ Price : $8.95]

FDA says it receives over 1,000 adverse event reports each year related to unretrieved device fragments (UDF) left in patients aft...

FDA Approves Mircera Anemia Treatment

[ Price : $8.95]

FDA approves Roches erythropoietin receptor activator Mircera for treating chronic kidney disease anemia.